Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 9, 2012, Pages 1546-1552

  Park, Sun Min ^a   Choi, Moon Suk ^a   Sohn, Nak Won ^a   Shin, Jung Won ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Cytokine; Lipopolysaccharide; Microglia; Neuroinflammation

Indexed keywords

CALCIUM BINDING PROTEIN; CYCLOOXYGENASE 2; GINSENOSIDE RG 3; IBA1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GINSENOSIDE; IMMUNOLOGIC FACTOR; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG STRUCTURE; GENE EXPRESSION; IMMUNOMODULATION; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; INFLAMMATION; METABOLISM; PANAX; PHYTOTHERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; GINSENOSIDES; IMMUNOLOGIC FACTORS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; RNA, MESSENGER;

EID: 84866039246     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00393     Document Type: Article

References (33)

1. Wee Yong V. Inflammation in neurological disorders: a help or a hindrance? Neuroscientist, 16, 408-420 (2010).
2. Harry GJ, Kraft AD. Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin. Drug Metab. Toxicol., 4, 1265-1277 (2008).
3. Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol. Res., 26, 884-892 (2004).
4. Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol., 62, 127-136 (2003).
5. McGeer EG, McGeer PL. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J. Alz heimer's Dis., 19, 355-361 (2010).
6. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron, 39, 889-909 (2003).
7. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol., 58, 1685-1693 (1999).
8. 3 on cerebral ischemia in rats. Neurosci. Lett., 374, 92-97 (2005).
9. 3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain. Phytother. Res., 23, 486-491 (2009).
10. 2+ channel-mediated cell death in rat cortical neurons. Biochem. Biophys. Res. Commun., 365, 399-405 (2008).
11. 3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res., 1136, 190-199 (2007).
12. 3 against lipopolysaccharide-induced hepatic and renal injury in rats. Free Radic. Res., 41, 1181-1188 (2007).
13. 2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med., 72, 627-633 (2006).
14. 3 and its role in microglial activation. Biol. Pharm. Bull., 31, 1392-1396 (2008).
15. Jeong HK, Jou I, Joe EH. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp. Mol. Med., 42, 823-832 (2010).
16. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res., 57, 1-9 (1998).
17. Zhu J, Jiang Y, Wu L, Lu T, Xu G, Liu X. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience, 202, 342-351 (2012).
18. Konat GW, Kielian T, Marriott I. The role of Toll-like receptors in CNS response to microbial challenge. J. Neurochem., 99, 1-12 (2006).
19. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia, 55, 453-462 (2007).
20. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis., 14, 133-145 (2003).
21. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol., 8, 382-397 (2009).
22. 2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol. Pharm. Bull., 29, 1862-1867 (2006).
23. Hayden MS, Ghosh SNF. NF-κB in immunobiology. Cell Res., 21, 223-244 (2011).
24. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog. Neurobiol., 57, 563-581 (1999).
25. Consonni A, Morara S, Codazzi F, Grohovaz F, Zacchetti D. Inhibition of lipopolysaccharide-induced microglia activation by calcitonin gene related peptide and adrenomedullin. Mol. Cell. Neurosci., 48, 151-160 (2011).
26. Zhang D, Hu X, Qian L, Chen SH, Zhou H, Wilson B, Miller DS, Hong JS. Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity. J. Neuroinflammation, 8, 3-17 (2011).
27. Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y. Macrophage/microglia- specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma-dependent pathway. J. Biol. Chem., 277, 20026-20032 (2002).
28. Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke, 32, 1208-1215 (2001).
29. Sheng W, Zong Y, Mohammad A, Ajit D, Cui J, Han D, Hamilton JL, Simonyi A, Sun AY, Gu Z, Hong JS, Weisman GA, Sun GY. Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia. J. Neuroinflammation, 8, 121-136 (2011).
30. Li P, Lu J, Kaur C, Sivakumar V, Tan KL, Ling EA. Expression of cyclooxygenase-1/-2, microsomal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory mediators by PGE(2) in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells. Neuroscience, 164, 948-962 (2009).
31. Possel H, Noack H, Putzke J, Wolf G, Sies H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia, 32, 51-59 (2000).
32. Aïd S, Bosetti F. Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications. Biochimie, 93, 46-51 (2011).
33. 2 is critical to neurotoxicity from activated cerebral innate immunity. Glia, 52, 70-77 (2005).